ArticleMolecular medicine reports2022

Angiotensin II receptor type 1 blocker candesartan improves morphine tolerance by reducing morphine‑induced inflammatory response and cellular activation of BV2 cells via the PPARγ/AMPK signaling pathway.

Wenxin Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.